Holen Sie sich die Stockscreener-App
3.83
0.26%
0.01
Schlusskurs vom Vortag:
$3.82
Offen:
$3.84
24-Stunden-Volumen:
88,066
Relative Volume:
0.36
Marktkapitalisierung:
$216.26M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-2.5533
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
-2.05%
1M Leistung:
-10.51%
6M Leistung:
+43.98%
1J Leistung:
-31.61%
1-Tages-Spanne:
$3.78
$3.99
1-Wochen-Bereich:
$3.78
$4.245
52-Wochen-Spanne:
$2.20
$5.98
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.83 | 215.70M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan - TipRanks
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Orchestra BioMed Grants Stock Options to New Employees as Part of 2025 Inducement Plan - Quiver Quantitative
Does Orchestra BioMed Holdings Inc. outperform in volatile marketsJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
Targets Report: How Orchestra BioMed Holdings Inc. stock performs after earningsJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
How sensitive is Orchestra BioMed Holdings Inc. to inflation2025 Trade Ideas & Fast Exit/Entry Strategy Plans - mfd.ru
MACD Signal: What is Orchestra BioMed Holdings Incs 5 year growth outlookEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Stock Recap: Is Daktronics Inc gaining market shareWeekly Stock Analysis & Risk Managed Investment Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Short Covering: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Year in Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Guidance Update: Does Orchestra BioMed Holdings Inc stock benefit from AI growth2025 Winners & Losers & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Risk Report: Is Rafael Holdings Inc affected by consumer sentimentShare Buyback & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% - Yahoo Finance
Aug Setups: What is Orchestra BioMed Holdings Inc. s 5 year growth outlookWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting - MSN
AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO - Defense World
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Retail Trends: Does PNTG have strong fundamentalsQuarterly Trade Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Support Test: Is Orchestra BioMed Holdings Inc stock a contrarian buyQuarterly Performance Summary & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Retail Trends: Should value investors consider Orchestra BioMed Holdings Inc - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
Orchestra BioMed Holdings, Inc. to Receive Proceeds from Vivasure Acquisition - TradingView
Early bet on vessel-closure patch could bring this firm $21M windfall - Stock Titan
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - Sahm
Assessing Orchestra BioMed Hldgs: Insights From 4 Financial Analysts - Benzinga
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap touched US$251m last week, benefiting both retail investors who own 41% as well as institutions - Sahm
Can Orchestra BioMed Holdings Inc. stock continue upward trendForecast Cut & Long-Term Growth Portfolio Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock rebound after recent weakness2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
Published on: 2026-01-09 01:26:31 - Улправда
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Update & Daily Chart Pattern Signal Reports - ulpravda.ru
Is Orchestra BioMed Holdings Inc. stock a safe buy before earningsBreakout Watch & Daily Profit Focused Stock Screening - Улправда
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Orchestra BioMed (NASDAQ:OBIO) Shares Up 0.2% – Here’s Why - Defense World
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs - Insider Monkey
Orchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025 - MSN
Orchestra BioMed Grants New Hire Stock Options as Clinical Programs Advance - MSN
What drives Orchestra BioMed Holdings Inc stock priceEarnings Beat Highlights & Receive Monthly Expert Trading Blueprints - earlytimes.in
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to NASDAQ Biotechnology Index - marketscreener.com
Why Orchestra BioMed Holdings Inc. stock is in analyst buy zone2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Buyout Rumor: Can Orchestra BioMed Holdings Inc. stock rebound after recent weaknessPortfolio Gains Summary & Capital Protection Trade Alerts - Улправда
What dividend safety score for Orchestra BioMed Holdings Inc. stockWeekly Stock Recap & AI Based Buy/Sell Signal Reports - DonanımHaber
S P Trends: Is Orchestra BioMed Holdings Inc stock a safe buy before earningsQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Orchestra BioMed Holdings Inc. stock is favored by top institutionsRisk Management & Growth Focused Investment Plans - Улправда
Will Orchestra BioMed Holdings Inc. stock maintain growth storyDollar Strength & Verified High Yield Trade Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock deliver consistent earnings growthMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - Улправда
How Orchestra BioMed Holdings Inc. stock performs in high volatility marketsJuly 2025 Chart Watch & Growth Focused Stock Pick Reports - bollywoodhelpline.com
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):